相关实验视频
Updated: Jun 23, 2025

04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
246
,双极性障碍的黄金标准药物:对当前临床研究的分析
Magdalena Airainer1, Roland Seifert2
1Institute of Pharmacology, Hannover Medical School, Carl-Neuberg-Straße 1, D-30625, Hannover, Germany.
Naunyn-Schmiedeberg's archives of pharmacology
|June 25, 2024
概括
仍然是双相情感障碍的关键治疗方法,对躁狂,抑郁和自杀症状有效. 最近的研究证实了它的有效性和安全性,特别是在辅助疗法中,尽管在特定情况下存在替代方案.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床神经科学 临床神经科学
背景情况:
- 是治疗双相情感障碍的黄金标准.
- 尽管在预防躁狂,抑郁和自杀症状方面具有有效性,但的使用是有限的.
- 药物不良反应和监测的需要需要对疗法的持续研究.
研究的目的:
- 系统地审查和批判性地分析过去7年发表的关于治疗双相情感障碍的治疗的临床研究.
- 为提供的有效性,耐受性和安全性的最新概述.
- 为了告知和改进双相情感障碍的药物治疗.
主要方法:
- 对治疗双相情感障碍的疗法的59项临床研究进行了系统审查和批判性分析.
- 研究被分为单疗法,与安慰剂/药物以及+辅助疗法子组.
- 分析包括研究持续时间,对躁狂症状的疗效,复发率,神经保护和附加治疗结果.
主要成果:
- 在改善躁狂症状方面表现出优于阿里皮普拉,瓦尔酸和奎提亚平的优势.
- 治疗的复发率低于酸,神经保护作用强于氨酸.
- 许多的补充疗法显示出积极的效果,而塞特拉林增加了研究中断.
结论:
- 是一种安全有效的双相情绪障碍治疗方法,特别是用于躁狂,抑郁和自杀症状的预防.
- 辅助疗法可以增强的治疗结果.
- 在特定情况下,可以考虑替代性治疗,如RISPERIDONE和QUETIAPINE用于儿童.
相关概念视频
Mania and Antimanic Drugs: Overview
168
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
168
Bipolar Disorder
65
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
65
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Psychosis: Goals of Pharmacotherapy
122
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
122
Electroconvulsive Therapy
31
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
31
Psychosis and Antipsychotic Drugs: Overview
234
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
234

